Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-23 to 2025-10-23
Current total value of award: $7482.86
Description: 8511660966!HUMAN PAPILLOMAVIRUS VACCINE